dx.doi.org/10.1038/bjc.2015.331, hdl.handle.net/1765/89138
British Journal of Cancer
Erasmus MC: University Medical Center Rotterdam

Cardillo, G, Mokhles, S, Williams, N, Macbeth, F, Russell, C, & Treasure, T. (2015). Comment on: 'KRAS and BRAF mutations are prognostic biomarkers in patients undergoing lung metastasectomy of colorectal cancer.' Variation in survival associated with proto-oncongenes is not evidence for effectiveness of lung metastasectomy. British Journal of Cancer, 113(11). doi:10.1038/bjc.2015.331